Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others


Acute exacerbation in interstitial lung disease

Alhamad Esam H, Cal Joseph G, Alrajhi Nuha N, AlBoukai Ahmad A

Year : 2021| Volume: 16| Issue : 2 | Page no: 178-187

   This article has been cited by
1 Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
MohammedAyaz Khan, Nahed Sherbini, Sami Alyami, Abdullah Al-Harbi, Majed Al-Ghamdi, Suliman Alrajhi, Rajkumar Rajendram, Hamdan Al-Jahdali
Annals of Thoracic Medicine. 2023; 18(1): 45
[Pubmed]  [Google Scholar] [DOI]
2 Deciding a Treatment Plan for an Older Patient With Severe Idiopathic Pulmonary Fibrosis: A Case Report
Yusuke Akashi, Yuta Horinishi, Chiaki Sano, Ryuichi Ohta
Cureus. 2023;
[Pubmed]  [Google Scholar] [DOI]
3 COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk Factors
Bianca Beghé, Stefania Cerri, Leonardo M. Fabbri, Alessandro Marchioni
International Journal of Molecular Sciences. 2021; 22(17): 9292
[Pubmed]  [Google Scholar] [DOI]


Read this article